Radiotherapy plus hormone therapy cuts prostate cancer death in half, shows long-term study
Combination treatment more than halves mortality rates for prostate cancer, reports Norwegian health journal Dagens Medisin.
Jan 30, 2014
0
0
Combination treatment more than halves mortality rates for prostate cancer, reports Norwegian health journal Dagens Medisin.
Jan 30, 2014
0
0
(HealthDay)—Prostate cancer patients who take the cholesterol-lowering drugs known as statins appear to face a lower risk of death from their disease, new Canadian research suggests.
Nov 5, 2013
2
0
Men who are overweight or obese when they are diagnosed with prostate cancer are more likely to die from the disease than men who are of healthy weight, according to a Kaiser Permanente study published today in the journal ...
Oct 29, 2013
0
0
(HealthDay)—Among elderly men with diabetes, increased cumulative duration of metformin following a prostate cancer (PC) diagnosis correlates with decreased all-cause and PC-specific mortality, according to a study published ...
Aug 8, 2013
0
0
(Medical Xpress)—What factors influence a man when he is choosing treatment for prostate cancer? Race and evolving treatment recommendations for prostate cancer both play roles.
Jun 12, 2013
0
0
Patients with prostate cancer that has metastasized, or spread, to other parts of the body face a significantly higher risk of dying when visiting a hospital emergency department on the weekend instead of on a weekday, according ...
May 5, 2013
0
0
Focusing prostate cancer testing on men at highest risk of developing the disease is likely to improve the ratio between benefits and the harms of screening, suggests a paper published today in BMJ.
Apr 16, 2013
0
0
(Medical Xpress)—The digital rectal exam is an important screening test that can discover prostate cancer that a prostate-specific antigen or PSA test may not, despite the higher sensitivity of the PSA test, according to ...
Mar 18, 2013
0
0
Men who participate in biennial PSA based screening have a lower risk of being diagnosed as well as dying from prostate cancer up to 9 years after their last PSA test, according to the results of a new study to be presented ...
Mar 18, 2013
0
0
What's most important to a man as he decides whether or not to undergo prostate-specific antigen- PSA- screening for prostate cancer? What does he value most about the screening? And what's the best way to present the information ...
Feb 11, 2013
0
0